Rebooting Human Immunology

Annual Review of Immunology

Volumn 36, Issue , 2018, Pages 843-864

  Davis, Mark M ^a   Brodin, Petter ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CMV; Human evolution; Human immunology; Systems immunology

Indexed keywords

ARTICLE; B LYMPHOCYTE; EVOLUTION; GENETIC HETEROGENEITY; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGIST; IMMUNOLOGY; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; ANIMAL MODEL; BIOLOGICAL VARIATION; HOST PATHOGEN INTERACTION; IMMUNOLOGICAL MEMORY; METABOLISM; PHYSIOLOGY;

LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMALS; B-LYMPHOCYTES; BIOLOGICAL EVOLUTION; BIOLOGICAL VARIATION, POPULATION; CLONAL DELETION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGIC MEMORY; MODELS, ANIMAL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 85045915694     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-042617-053206     Document Type: Article

References (96)

1. Steinman RM, Mellman I. 2004. Immunotherapy: bewitched, bothered, and bewildered no more. Science 305(5681):197-200
2. Herrath von MG, Nepom GT. 2005. Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity. J. Exp. Med. 202(9):1159-62
3. Davis MM. 2008. A prescription for human immunology. Immunity 29(6):835-38
4. Quintana-Murci L, Alcais A, Abel L, Casanova J-L. 2007. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol. 8(11):1165-71
5. Davis MM, Tato CM, Furman D. 2017. Systems immunology: just getting started. Nat. Immunol. 18(7):725-32
6. Wrammert J, Smith K,Miller J, Langley WA, Kokko K, et al. 2008. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453(7195):667-71
7. Raki M, Fallang L-E, Brottveit M, Bergseng E, Quarsten H, et al. 2007. Tetramer visualization of guthoming gluten-specific T cells in the peripheral blood of celiac disease patients. PNAS 104(8):2831-36
8. Brodin P, Davis MM. 2017. Human immune system variation. Nat. Rev. Immunol. 17(1):21-29
9. Fredolini C, Bystr om S, Pin E, Edfors F, Tamburro D, et al. 2016. Immunocapture strategies in translational proteomics. Expert Rev. Proteom. 13(1):83-98
10. Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. 2011. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 39(15):e102
11. Gold L, AyersD, Bertino J, Bock C, Bock A, et al. 2010. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLOS ONE 5(12):e15004
12. Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD, et al. 2015. Comprehensive serological profiling of human populations using a synthetic human virome. Science 348(6239):aaa0698
13. Lipkin WI. 2015. A vision for investigating themicrobiology of health and disease. J. Infect.Dis. 212(Suppl. 1):26-30
14. Mohn KG-I, Brokstad KA, Pathirana RD, Bredholt G, Jul-LarsenA , et al. 2016. Live attenuated influenza vaccine in children induces B-cell responses in tonsils. J. Infect. Dis. 214(5):722-31
15. Mestas J, Hughes CCW. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172(5):2731-38
16. Han A, Glanville J, Hansmann L, Davis MM. 2014. Linking T-cell receptor sequence to functional phenotype at the single-cell level. Nat. Biotechnol. 32(7):684-92. Corrigendum. 2015. Nat. Biotechnol. 33:210
17. Carlson CS, Emerson RO, Sherwood AM, Desmarais C, Chung M-W, et al. 2013. Using synthetic templates to design an unbiased multiplex PCR assay. Nat. Commun. 4:ncomms3680
18. Stubbington MJT, L onnberg T, Proserpio V, Clare S, Speak AO, et al. 2016. T cell fate and clonality inference from single-cell transcriptomes. Nat. Methods 13(4):329-32
19. Glanville J, Huang H, Nau A, Hatton O, Wagar LE, et al. 2017. Identifying specificity groups in the T cell receptor repertoire. Nature 547(7661):94-98
20. Dash P, Fiore-Gartland AJ, Hertz T, Wang GC, Sharma S, et al. 2017. Quantifiable predictive features define epitope-specific T cell receptor repertoires. Nature 547(7661):89-93
21. Davis MM, Bjorkman PJ. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334(6181):395-402
22. Rudolph MG, Wilson IA. 2002. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14(1):52-65
23. LindestamArlehamnCS, McKinneyDM, Carpenter C, Paul S, RozotV, et al. 2016.Aquantitative analysis of complexity of human pathogen-specific CD4 T cell responses in healthy M. tuberculosis infected South Africans. PLOS Pathog. 12(7):e1005760
24. Chen DS, Mellman I. 2017. Elements of cancer immunity and the cancer-immune set point. Nature 541(7637):321-30
25. Birnbaum ME,Mendoza JL, SethiDK, Dong S, Glanville J, et al. 2014. Deconstructing the peptide-MHC specificity of T cell recognition. Cell 157(5):1073-87
26. Gee MH, Han A, Lofgren SM, Beausang JF, Mendoza JL, et al. 2017. Antigen identification for orphan T cell receptors expressed on tumor-infiltrating lymphocytes. Cell 172:549-63
27. Andres-Terre M, McGuire HM, Pouliot Y, Bongen E, Sweeney TE, et al. 2015. Integrated, multicohort analysis identifies conserved transcriptional signatures acrossmultiple respiratory viruses. Immunity 43(6):1199-211
28. Sweeney TE, Braviak L, Tato CM, Khatri P. 2016. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir. Med. 4(3):213-24
29. Khatri P, Roedder S, Kimura N, De Vusser K, Morgan AA, et al. 2013. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J. Exp. Med. 210(11):2205-21
30. Sweeney TE, Shidham A, Wong HR, Khatri P. 2015. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci. Transl. Med. 7(287):287ra71
31. Sparks R, Lau WW, Tsang JS. 2016. Expanding the immunology toolbox: embracing public-data reuse and crowdsourcing. Immunity 45(6):1191-204
32. Bhattacharya S, Andorf S, Gomes L, Dunn P, Schaefer H, et al. 2014. ImmPort: disseminating data to the public for the future of immunology. Immunol. Res. 58(2-3):234-39
33. Brusic V, Gottardo R, Kleinstein SH, DavisMM,HIPC Steer.Comm. 2014. Computational resources for high-dimensional immune analysis from the Human Immunology Project Consortium. Nat. Biotechnol. 32(2):146-48
34. Carpenter DJ, Granot T, Matsuoka N, Senda T, Kumar BV, et al. 2018. Human immunology studies using organ donors: impact of clinical variations on immune parameters in tissues and circulation. Am. J. Transplant. 18:74-88
35. McCune JM, Namikawa R, Kaneshima H, Shultz LD, LiebermanM,Weissman IL. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241(4873):1632-39
36. Legrand N, Ploss A, Balling R, Becker PD, Borsotti C, et al. 2009. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 6(1):5-9
37. Rongvaux A, Willinger T, Martinek J, Strowig T, Gearty SV, et al. 2014. Development and function of human innate immune cells in a humanized mouse model. Nat. Biotechnol. 32(4):364-72
38. Yu H, Borsotti C, Schickel J-N, Zhu S, Strowig T, et al. 2017. A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production. Blood 129(8):959-69
39. Philip VM, Sokoloff G, Ackert-Bicknell CL, Striz M, Branstetter L, et al. 2011. Genetic analysis in the Collaborative Cross breeding population. Genome Res. 21(8):1223-38
40. Civelek M, Lusis AJ. 2014. Systems genetics approaches to understand complex traits. Nat. Rev. Genet. 15(1):34-48
41. Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, et al. 2016. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532(7600):512-16
42. Carr EJ, Dooley J, Garcia-Perez JE, Lagou V, Lee JC, et al. 2016. The cellular composition of the human immune system is shaped by age and cohabitation. Nat. Immunol. 17(4):461-68
43. Tsang JS, Schwartzberg PL, Kotliarov Y, Biancotto A, Xie Z, et al. 2014. Global analyses of human immune variation reveal baseline predictors of postvaccination responses. Cell 157(2):499-513
44. Shen-Orr SS, Furman D, Kidd BA, Hadad F,Lovelace P, et al. 2016. Defective signaling in the JAK-STAT pathway tracks with chronic inflammation and cardiovascular risk in aging humans. Cell Syst. 3(4):374-84
45. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, et al. 2009. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10(1):116-25
46. Nakaya HI,Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, et al. 2011. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12(8):786-95
47. Furman D, Jojic V, Kidd B, Shen-Orr S, Price J, et al. 2013. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol. Syst. Biol. 9(1):659-59
48. Sobolev O, BindaE,O'Farrell S, Lorenc A, Pradines J, et al. 2016. Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. Nat. Immunol. 17(2):204-13
49. Nakaya HI, Hagan T, Duraisingham SS, Lee EK, Kwissa M, et al. 2015. Systems analysis of immunity to influenza vaccination acrossmultiple years and in diverse populations reveals shared molecular signatures. Immunity 43(6):1186-98
50. Oh JZ, Ravindran R, Chassaing B, Carvalho FA, Maddur MS, et al. 2014. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41(3):478-92
51. Ravindran R, Khan N, Nakaya HI, Li S, Loebbermann J, et al. 2014. Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation. Science 343(6168):313-17
52. Kaczorowski KJ, Shekhar K, Nkulikiyimfura D, Dekker CL, Maecker H, et al. 2017. Continuous immunotypes describe human immune variation and predict diverse responses. PNAS 17:201705065
53. LekM, Karczewski KJ,Minikel EV, Samocha KE, Banks E, et al. 2016. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285-91
54. Cetani F, Barbesino G, Borsari S, Pardi E, Cianferotti L, et al. 2001. A novel mutation of the autoimmune regulator gene in an Italian kindredwith autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 86(10):4747-52
55. Oftedal BE, Hellesen A, Erichsen MM, Bratland E, Vardi A, et al. 2015. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity 42(6):1185-96
56. Kuehn HS, Ouyang W, Lo B, Deenick EK, Niemela JE, et al. 2014. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345(6204):1623-27
57. Brodin P, Jojic V, Gao T, Bhattacharya S, Angel CJL, et al. 2015. Variation in the human immune system is largely driven by non-heritable influences. Cell 160(1-2):37-47
58. Roederer M, Quaye L,Mangino M, Beddall MH,Mahnke Y, et al. 2015. The genetic architecture of the human immune system: a bioresource for autoimmunity and disease pathogenesis. Cell 161(2):387-403
59. Orru V, Steri M, Sole G, Sidore C, Virdis F, et al. 2013. Genetic variants regulating immune cell levels in health and disease. Cell 155(1):242-56
60. ManginoM, RoedererM, Beddall MH,Nestle FO, Spector TD. 2017. Innate and adaptive immune traits are differentially affected by genetic and environmental factors. Nat. Commun. 8:13850
61. Evans DM, Frazer IH, Martin NG. 1999. Genetic and environmental causes of variation in basal levels of blood cells. Twin Res. 2(4):250-57
62. H ohler T, Reuss E, Evers N, Dietrich E, Rittner C, et al. 2002. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 360(9338):991-95
63. Yan K, Cai W, Cao F, SunH, Chen S, et al. 2013. Genetic effects have a dominant role on poor responses to infant vaccination to hepatitis B virus. J. Hum. Genet. 58(5):293-97
64. Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, et al. 2005. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202(5):673-85
65. Sansoni P, Vescovini R, Fagnoni FF, Akbar A, Arens R, et al. 2014. New advances in CMV and immunosenescence. Exp. Gerontol. 55:54-62
66. Furman D, Jojic V, Sharma S, Shen-Orr SS, Angel CJL, et al. 2015. Cytomegalovirus infection enhances the immune response to influenza. Sci. Transl. Med. 7(281):281ra43
67. Hansen SG, Sacha JB, Hughes CM, Ford JC, Burwitz BJ, et al. 2013. Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science 340(6135):1237874
68. Strachan DP. 1989. Hay fever, hygiene, and household size. BMJ 299(6710):1259-60
69. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, et al. 2011. Helicobacter pylori infection prevents allergic asthma in mousemodels through the induction of regulatoryTcells. J. Clin. Investig. 121(8):3088-93
70. Russell SL, Gold MJ, Willing BP, Thorson L, McNagny KM, Finlay BB. 2013. Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes 4(2):158-64
71. Arrieta M-C, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, et al. 2015. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 7(307):307ra152
72. Barreiro LB, Quintana-Murci L. 2010. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat. Rev. Genet. 11(1):17-30
73. Laayouni H, Oosting M, Luisi P, Ioana M, Alonso S, et al. 2014. Convergent evolution in European and Roma populations reveals pressure exerted by plague on Toll-like receptors. PNAS 111(7):2668-73
74. Abi-Rached L, JobinMJ, Kulkarni S, McWhinnie A, Dalva K, et al. 2011. The shaping of modern human immune systems by multiregional admixture with archaic humans. Science 334(6052):89-94
75. Deschamps M, Laval G, Fagny M, Itan Y, Abel L, et al. 2016. Genomic signatures of selective pressures and introgression from archaic hominins at human innate immunity genes. Am. J. Hum. Genet. 98(1):5-21
76. Burnet FM. 1959. The Clonal Selection Theory of Acquired Immunity.Nashville, TN: Vanderbilt Univ. Press
77. Nossal GJ. 1983. Cellular mechanisms of immunologic tolerance. Annu. Rev. Immunol. 1:33-62
78. Kappler JW, Roehm N, Marrack P. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49(2):273-80
79. Frankel WN, Rudy C, Coffin JM, Huber BT. 1991. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature 349(6309):526-28
80. Woodland DL, Happ MP, Gollob KJ, Palmer E. 1991. An endogenous retrovirus mediating deletion of αβT cells? Nature 349(6309):529-30
81. Dyson PJ, Knight AM, Fairchild S, Simpson E, Tomonari K. 1991. Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes. Nature 349(6309):531-32
82. Marrack P, Kushnir E, Kappler J. 1991. A maternally inherited superantigen encoded by a mammary tumour virus. Nature 349(6309):524-26
83. Herman A, Kappler JW, Marrack P, Pullen AM. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-72
84. von Boehmer H. 1990. Developmental biology of T cells in T cell-receptor transgenic mice. Annu. Rev. Immunol. 8:531-56
85. Altman JD, Moss PA,Goulder PJ, BarouchDH, McHeyzer-WilliamsMG, et al. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274(5284):94-96
86. Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, et al. 2006. Design and use of conditional MHC class I ligands. Nat. Med. 12(2):246-51
87. Moon JJ, Chu HH, PepperM,McSorley SJ, Jameson SC, et al. 2007. Naive CD4+ T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27(2):203-13
88. Yu W, Jiang N, Ebert PJR, Kidd BA,M uller S, et al. 2015. Clonal deletion prunes but does not eliminate self-specific αβCD8+ T lymphocytes. Immunity 42(5):929-41
89. Legoux FP, Lim J-B, Cauley AW, Dikiy S, Ertelt J, et al. 2015. CD4+ T cell tolerance to tissue-restricted self antigens is mediated by antigen-specific regulatory T cells rather than deletion. Immunity 43(5):896-908
90. Su LF, Kidd BA, Han A, Kotzin JJ, Davis MM. 2013. Virus-specific CD4+ memory-phenotype T cells are abundant in unexposed adults. Immunity 38(2):373-83
91. Akue AD, Lee J-Y, Jameson SC. 2012. Derivation and maintenance of virtual memory CD8 T cells. J. Immunol. 188(6):2516-23
92. Selin LK, Varga SM, Wong IC, Welsh RM. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188(9):1705-15
93. Mason D. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19(9):395-404
94. Ebert PJR, Jiang S, Xie J, Li Q-J, Davis MM. 2009. An endogenous positively selecting peptide enhances matureTcell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat. Immunol. 10(11):1162-69
95. Lo W-L, Felix NJ, Walters JJ, Rohrs H, Gross ML, Allen PM. 2009. An endogenous peptide positively selects and augments the activation and survival of peripheralCD4+ Tcells. Nat. Immunol. 10(11):1155-61
96. Kuhn TS. 1970. The Structure of Scientific Revolutions. Chicago: Univ. Chicago Press